WebApr 10, 2024 · Cue Health (HLTH) Financial Statements: Income - Stock Analysis Cue Health Inc. ( HLTH) NASDAQ: HLTH · IEX Real-Time Price · USD Add to Watchlist 1.88 … WebMar 29, 2024 · Cue Health had a net income of $34.2 million, or $.22 per share, in the recently completed quarter compared to a net loss of $19.5 million, or $1.16 per share, in Q4 a year ago. The consensus Wall Street EPS estimate was $.10.
Cue Health Reports Strong Fourth Quarter and Full Year 2024 …
WebSep 24, 2024 · Total Raised $896.03M Investors Count 26 Deal Terms 3 Funding, Valuation & Revenue 10 Fundings Cue Health's latest funding round was a IPO for $200M on September 24, 2024. Cue Health's latest post-money valuation is from September 2024. Sign up for a free trial to see Cue Health's valuations in September 2024 and more. … WebNov 13, 2024 · Cue Health Inc. (NASDAQ:HLTH) Q3 2024 Earnings Conference Call November 10, 2024 4:30 PM ET. Company Participants. Caroline Corner - Westwicke … cia project stargate drug trafficking
CUE Stock Price Cue Biopharma Inc. Stock Quote (U.S.: Nasdaq
WebMar 24, 2024 · Annual Income Statement. Fiscal Year end for Cue Health Inc falls in the month of December . All items in Millions except EPS data. Selling & Adminstrative & Depr. WebMar 29, 2024 · SAN DIEGO -- (BUSINESS WIRE)--Mar. 29, 2024-- Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, (“Cue") today reported financial results for fourth quarter and full year 2024. Key Highlights Reported total revenue of $192.5 million for the fourth quarter of 2024, compared to $13.3M in the fourth quarter of 2024 Web2 days ago · BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, announced today the appointment of industry veteran Patrick … cia psychological tests